BRD4 and breast carcinoma: BRD4 dysfunction is associated with the tumorigenesis and progression of a variety of cancers, including acute myeloid leukemia, colon cancer, Burkitt's lymphoma, breast cancer, diffused large B-cell lymphoma, multiple myeloma, and ovarian cancer [4, 8–12].